The role of the Bcl-2 protein family in cancer

Seminars in Cancer Biology

Volumn 13, Issue 2, 2003, Pages 115-123

  Coultas, Leigh ^a   Strasser, Andreas ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Anti cancer therapy; Apoptosis; Bcl 2 protein family; Tumourigenesis

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; CANCER; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 0037376405     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-579X(02)00129-3     Document Type: Review

References (83)

1. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2239-2244.
2. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
3. Gross A., McDonnell J.M., Korsmeyer S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911.
4. Strasser A., O'Connor L., Dixit V.M. Apoptosis signaling. Annu. Rev. Biochem. 69:2000;217-245.
5. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
6. Huang D.C.S., Strasser A. BH3-only proteins - essential initiators of apoptotic cell death. Cell. 103:2000;839-842.
7. Jacobson M.D., Weil M., Raff M.C. Programmed cell death in animal development. Cell. 88:1997;347-354.
8. Newton K., Strasser A. Cell death control in lymphocytes. Adv. Immunol. 76:2001;179-226.
9. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
10. Strasser A., Harris A.W., Bath M.L., Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:1990;331-333.
11. Strasser A., Whittingham S., Vaux D.L., Bath M.L., Adams J.M., Cory S.et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 88:1991;8661-8665.
12. Bouillet P., Metcalf D., Huang D.C.S., Tarlinton D.M., Kay T.W.H., Köntgen F.et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1999;1735-1738.
13. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.-C., Coultas L., Puthalakath H.et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:2002;922-926.
14. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
15. Bouillet P., Cory S., Zhang L.-C., Strasser A., Adams J.M. Degenerative disorders caused by Bcl-2 deficiency are prevented by loss of its BH3-only antagonist Bim. Dev. Cell. 1:2001;645-653.
16. Strasser A., Harris A.W., Huang D.C.S., Krammer P.H., Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:1995;6136-6147.
17. Newton K., Harris A.W., Bath M.L., Smith K.G.C., Strasser A. A dominant interfering mutant of FADD/Mort1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17:1998;706-718.
18. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
19. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314-317.
20. Rieux-Laucat F., Le Deist F., Hivroz C., Roberts I.A.G., Debatin K.M., Fischer A.et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 268:1995;1347-1349.
21. Traver D., Akashi K., Weissman I.L., Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity. 9:1998;47-57.
22. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T.et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:1994;969-976.
23. Newton K., Harris A.W., Strasser A. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19:2000;931-941.
24. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
25. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 407:2000;784-788.
26. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
27. Suzuki M., Youle R.J., Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell. 103:2000;645-654.
28. Lindsten T., Ross A.J., King A., Zong W., Rathmell J.C., Shiels H.A.et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell. 6:2000;1389-1399.
29. Zong W.X., Lindsten T., Ross A.J., MacGregor G.R., Thompson C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:2001;1481-1486.
30. L sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711.
31. L-Bak peptide complex: recognition between regulators of apoptosis. Science. 275:1997;983-986.
32. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1311.
33. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2001;2922-2933.
34. Conradt B., Horvitz H.R. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell. 93:1998;519-529.
35. Hengartner M.O., Horvitz H.R. Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature. 369:1994;318-320.
36. Moriishi K., Huang D.C.S., Cory S., Adams J.M. Bcl-2 family members do not inhibit apoptosis by binding the caspase-activator Apaf-1. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9683-9688.
37. L. J. Cell Biol. 149:2000;623-634.
38. Dorstyn L., Read S., Cakouros D., Huh J.R., Hay B.A., Kumar S. The role of cytochrome c in caspase activation in Drosophila melanogaster cells. J. Cell Biol. 156:2002;1089-1098.
39. Zimmermann K.C., Ricci J.E., Droin N.M., Green D.R. The role of ARK in stress-induced apoptosis in Drosophila cells. J. Cell Biol. 156:2002;1077-1087.
40. Guo Y., Srinivasula S.M., Druilhe A., Fernandes-Alnemri T., Alnemri E.S. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 277:2002;13430-13437.
41. Hildeman D.A., Zhu Y., Mitchell T.C., Bouillet P., Strasser A., Kappler J.et al. Activated T cell death in vivo mediated by pro-apoptotic Bcl-2 family member, Bim. Immunity. 16:2002;759-767.
42. Strasser A., Harris A.W., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;889-899.
43. Sentman C.L., Shutter J.R., Hockenbery D., Kanagawa O., Korsmeyer S.J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:1991;879-888.
44. Putcha G.V., Moulder K.L., Golden J.P., Bouillet P., Adams J.M., Strasser A.et al. Induction of Bim, a proapoptotic BH3-only Bcl-2 family member, is critical for neuronal apoptosis. Neuron. 29:2001;615-628.
45. Whitfield J., Neame S.J., Paquet L., Bernard O., Ham J. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron. 29:2001;629-643.
46. Yin X.-M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B.et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 400:1999;886-891.
47. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T.et al. Noxa, a BH3-only member of the bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058.
48. Yu J., Zhang L., Hwang P.M., Kinzler K.W., Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell. 7:2001;673-682.
49. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7:2001;683-694.
50. Han J., Flemington C., Houghton A.B., Gu Z., Zambetti G.P., Lutz R.J.et al. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc. Natl. Acad. Sci. U.S.A. 98:2001;11318-11323.
51. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 13:2001;555-562.
52. Puthalakath H., Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9:2002;505-512.
53. Harris C.A., Johnson E.M. Jr. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J. Biol. Chem. 276:2001;37754-37760.
54. L. Cell. 87:1996;619-628.
55. Puthalakath H., Huang D.C.S., O'Reilly L.A., King S.M., Strasser A. The pro-apoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell. 3:1999;287-296.
56. Puthalakath H., Villunger A., O'Reilly L.A., Beaumont J.G., Coultas L., Cheney R.E.et al. Bmf: a pro-apoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science. 293:2001;1829-1832.
57. Li H., Zhu H., Xu C.-J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
58. Luo X., Budlhardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
59. Coultas L., Huang D.C.S., Adams J.M., Strasser A. Pro-apoptotic BH3-only Bcl-2 family members in vertebrate model organisms suitable for genetic experimentation. Cell Death Differ. 9:2002;1165-1166.
60. Tsujimoto Y., Finger L.R., Yunis J., Nowell P.C., Croce C.M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 226:1984;1097-1099.
61. Strasser A., Harris A.W., Cory S. Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene. 8:1993;1-9.
62. McDonnell T.J., Korsmeyer S.J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature. 349:1991;254-256.
63. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S.et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 318:1985;533-538.
64. Acton D., Domen J., Jacobs H., Vlaar M., Korsmeyer S., Berns A. Collaboration of PIM-1 and BCL-2 in lymphomagenesis. Curr. Top. Microbiol. Immunol. 182:1992;293-298.
65. Kumar A., Ta D., Henderson D., Mushinski J.F., Reed J.C., Kuus-Reichel K.et al. bcl2 and v-abl oncogenes cooperate to immortalize murine B cells that secrete antigen specific antibodies. Immunol. Lett. 65:1999;153-159.
66. Linette G.P., Hess J.L., Sentman C.L., Korsmeyer S.J. Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice. Blood. 86:1995;1255-1260.
67. Jäger R., Herzer U., Schenkel J., Weiher H. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene. 15:1997;1787-1795.
68. Naik P., Karrim J., Hanahan D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10:1996;2105-2116.
69. Zhou P., Levy N.B., Xie H., Qian L., Lee C.Y., Gascoyne R.D.et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood. 97:2001;3902-3909.
70. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
71. Strasser A., Harris A.W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339.
72. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A.J., Butel J.S.et al. Mice deficient for p53 are developmentally normal but are susceptible to spontaneous tumours. Nature. 356:1992;215-221.
73. Knudson C.M., Johnson G.M., Lin Y., Korsmeyer S.J. Bax accelerates tumorigenesis in p53-deficient mice. Cancer Res. 61:2001;659-665.
74. Yin C.Y., Knudson C.M., Korsmeyer S.J., Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 385:1997;637-640.
75. Shibata M.A., Liu M.L., Knudson M.C., Shibata E., Yoshidome K., Bandey T.et al. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO J. 18:1999;2692-2701.
76. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
77. Schmidt T., Korner K., Karsunky H., Korsmeyer S., Muller R., Moroy T. The activity of the murine bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53. Cell Death Differ. 6:1999;873-882.
78. Mathai J.P., Germain M., Marcellus R.C., Shore G.C. Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. Oncogene. 21:2002;2534-2544.
79. Evan G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1321.
80. Soengas M.S., Alarcón R.M., Yoshida H., Giaccia A.J., Hakem R., Mak T.W.et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 284:1999;156-159.
81. Brown J.M., Wouters B.G. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 59:1999;1391-1399.
82. Schmitt C.A., Rosenthal C.T., Lowe S.W. Genetic analysis of chemoresistance in primary murine lymphomas. Nat. Med. 6:2000;1029-1035.
83. Marsden V., O'Connor L., O'Reilly L.A., Silke J., Metcalf D., Ekert P.et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 419:2002;634-637.